1-4 of 4
Carter Van Waes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways

Xinping Yang, Hui Cheng, Jianhong Chen, Ru Wang, Anthony Saleh, Han Si, Steven Lee, Emine Guven-Maiorov, Ozlem Keskin, Attila Gursoy, Ruth Nussinov, Jugao Fang, Carter Van Waes, Zhong Chen
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (11): 1760–1774.
https://doi.org/10.1158/2326-6066.CIR-18-0832
Published: 01 November 2019
View article titled, Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways
Open the PDF for Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways in another window
Includes: Supplementary data
Journal Articles

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma

Linda Tran, Clint T. Allen, Roy Xiao, Ellen Moore, Ruth Davis, So-Jin Park, Katie Spielbauer, Carter Van Waes, Nicole C. Schmitt
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (12): 1141–1151.
https://doi.org/10.1158/2326-6066.CIR-17-0235
Published: 30 November 2017
View article titled, Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
Open the PDF for Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade

Ellen Moore, Paul E. Clavijo, Ruth Davis, Harrison Cash, Carter Van Waes, Young Kim, Clint Allen
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (12): 1061–1071.
https://doi.org/10.1158/2326-6066.CIR-16-0104
Published: 30 November 2016
View article titled, Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade
Open the PDF for Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade in another window
Includes: Supplementary data
Journal Articles

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers

Ellen C. Moore, Harrison A. Cash, Andria M. Caruso, Ravindra Uppaluri, James W. Hodge, Carter Van Waes, Clint T. Allen
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (7): 611–620.
https://doi.org/10.1158/2326-6066.CIR-15-0252
Published: 30 June 2016
View article titled, Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers
Open the PDF for Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers in another window
Includes: Supplementary data